Qube Research & Technologies (QRT)
BBNX icon

Qube Research & Technologies (QRT)’s Beta Bionics BBNX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-58,156
Closed -$583K – 4222
2026
Q1 		$583K Buy
58,156
+40,778
+235% +$603K ﹤0.01% 2683
2025
Q4 		$530K Buy
+17,378
New +$464K ﹤0.01% 2783

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BBNX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 58,156 shares — an estimated $583K sold.

Qube Research & Technologies (QRT) first reported a position in BBNX in Q4 2025 and held it in 2 quarters. The position peaked at $583K in Q1 2026. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 58,156 Beta Bionics shares in Q2 2026, an estimated $583K.
  • Qube Research & Technologies (QRT) first reported a position in Beta Bionics in Q4 2025 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Beta Bionics position peaked at $583K in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.